22:23:30 EDT Wed 23 Sep 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Marapharm Ventures Inc
Symbol MDM
Shares Issued 108,502,958
Close 2018-04-04 C$ 0.69
Recent Sedar Documents

ORIGINAL: Marapharm closes $1.72-million private placement

2018-04-04 16:10 ET - News Release

Received by email:

File: NR.CLOSE OF PP OVERSUBSCRIBED.docx

News Release                                April 4, 2018, Kelowna, BC
Marapharm Ventures Inc. Closes on Over-Subscribed Financing 
Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) ("Marapharm" or the "Company") is very pleased to announce 
--->the closing of the over-subscribed second and final tranche of its previously announced non-brokered private placement. 
--->Further to its press release, dated March 16th, 2018, the Company closed the second tranche for gross proceeds of $1,726
--->,754. through the issuance of 1,996,247 Units (the "Unit").

The non-brokered Private Placement had been originally announced as being comprised of 3,000,000 Units for total proceed
--->s of $2,595,000.  The closing numbers today reflect an increase of 3,545,007 Units for a total of $3,066,434.

The Company will pay an aggregate cash finder's fee of $82,632. and issue an aggregate of 95,529 finders' warrants (the 
--->"Finders Warrant").  Each non-transferable finder's warrant entitles the finder to acquire one common share at $0.87 for
---> 14 months from the closing of the private placement. 

Each Unit consists of one common share and one common share purchase warrant. Each transferable whole common share purch
--->ase warrant (the "Purchase Warrants") will entitle the holder to acquire one common share at $0.87. The Purchase Warrant
--->s may be exercised at any time until 12 months from the closing of the private placement.

All securities issued pursuant to this financing will be subject to resale restrictions for a period of four months and 
--->one day from closing under applicable securities legislation.

The net proceeds raised from the Unit Offering are intended to be used for further development of the Company's projects
---> in Las Vegas, Nevada  Washington State, Desert Hot Springs, California and general corporate purposes.

ABOUT MARAPHARM VENTURES INC.

www.marapharm.com

Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm h
--->as rapidly expanded to include having cultivation, production and dispensary locations in the key North American states 
--->of Washington, Nevada, and California, and are seeking expansion opportunities worldwide. 
FOR FURTHER INFORMATION:
www.marapharm.com or Linda Sampson, CEO 778-583-4476 email info@marapharm.com
SOCIAL MEDIA:
Facebook: facebook.com/marapharm Twitter: twitter.com/marapharm Web Program: marapharm.tv
STOCK EXCHANGES:
Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQX, and in
---> Europe, ticker symbol 2M0 on the FSE. Marapharm also trades on other recognized platforms in Europe including Stuttgart
--->, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE, the FSE nor the OTCQXtrademark has approved nor disapproved the contents of this press release. Neither
---> the CSE, the FSE nor the OTCQXtrademark accepts responsibility for the adequacy or accuracy of this release.
MARIJUANA INDUSTRY INVOLVEMENT:
Canadian listings (CSE) will remain in good standing as long as they provide the disclosure that is rightly required by 
--->regulators and complying with applicable licensing requirements and the regulatory framework enacted by the applicable s
--->tate in which they operate.
Marapharm owns marijuana licenses in California and Nevada. Marijuana is legal in each state however marijuana remains i
--->llegal under US federal law and the approach to enforcement of US federal law against marijuana is subject to change. Sh
--->areholders and investors need to be aware that adverse enforcement actions could affect their investments and that Marap
--->harm's ability to access private and public capital could be affected and or could not be available to support continuin
--->g operations. Marapharm's business is conducted in a manner consistent with state law and is in compliance with licensin
--->g requirements.

Copies of licenses are posted on Marapharm's website. Marapharm has internal compliance procedures in place and has comp
--->liance focused attorneys engaged in jurisdictions to monitor changes in laws for compliance with US federal and state la
--->w on an ongoing basis. These law firms inform any necessary changes to our policies and procedures for compliance in Can
--->ada and the US.

FORWARD - LOOKING STATEMENTS:
Certain statements contained in this news release constitute forward looking statements. The use of any of the words "an
--->ticipate", "continue", "estimate", "expect", 'may", "will", "project", "should", 'believe", and similar expressions are 
--->intended to identify forward- looking statements. These statements involve known and unknown risks, uncertainties and ot
--->her factors that may cause actual results or events to differ materially from those anticipated in such forward- looking
---> statements are based on reasonable assumption but no assurance can be given that these expectations will prove to be co
--->rrect and the forward-looking statements included in this news release should not be unduly relied upon.  



© 2020 Canjex Publishing Ltd. All rights reserved.